AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2013

Nov 19, 2013

32414_dirs_2013-11-19_f1a32c1a-b956-42ea-ba68-eb144fd64a36.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2013-11-19

Reporting Person: Gold Mark Stephen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-19	Common Stock	M	290	$1.073	Acquired	252987	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-19	Stock Option (right to buy)	$1.073	M	290	Disposed	2018-09-29	Common Stock (290)	Direct

Footnotes

F1: These shares include 107,690 shares held by Dr. Gold's wife and 125,523 shares held by MJSK, Ltd., an investment trust held by Dr. Gold's family.